Characterization of the zinc finger protein encoded by the WT1 Wilms' tumor locus
- PMID: 1662794
Characterization of the zinc finger protein encoded by the WT1 Wilms' tumor locus
Abstract
We analysed the biochemical properties of the transcription factor encoded by the putative tumor-suppressor gene present at the WT1 Wilms' tumor locus. A gene containing the full-length amino acid coding sequence of human wt1 was reconstructed from synthetic oligonucleotides and cloned into expression vectors for in vitro and in vivo protein synthesis. Polyclonal rabbit antibodies specific for the WT1 protein were raised to an Escherichia coli-produced 91 amino acid N-terminal segment and to a 136 amino acid C-terminal segment, which contains the zinc finger domain. WT1 produced by in vitro translation migrated as a 52 kDa protein on sodium dodecylsulfate-polyacrylamide gels and bound to the EGR consensus sequence in gel-retardation assays. Expression of the wt1 gene via transient transfection in COS-1 cells revealed a 52 kDa protein which was immunoprecipitated by both the N-terminal- and C-terminal-specific antisera. Immunofluorescence studies of wt1-transfected COS-1 cells revealed that the WT1 protein was localized to the nucleus. Metabolic labeling with [32P]orthophosphate failed to reveal significant phosphorylation of the WT1 protein in COS-1 cells. Two immunoreactive WT polypeptides of 52 and 54 kDa were observed in murine embryonic stem cells and COS-1 kidney cells and may represent previously identified splicing variants of WT1. These antisera should be useful in characterizing the structure and function of the WT1 protein in human Wilms' tumor specimens.
Similar articles
-
Identification of the cellular protein encoded by the human Wilms' tumor (WT1) gene.Oncogene. 1992 Dec;7(12):2545-8. Oncogene. 1992. PMID: 1334252
-
Wilms' tumor 1 splice variants have opposite effects on the tumorigenicity of adenovirus-transformed baby-rat kidney cells.Oncogene. 1996 Feb 1;12(3):537-46. Oncogene. 1996. PMID: 8637710
-
Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.Biochemistry. 1996 Sep 17;35(37):12070-6. doi: 10.1021/bi960758o. Biochemistry. 1996. PMID: 8810912
-
Wilms tumor and the WT1 gene.Exp Cell Res. 2001 Mar 10;264(1):74-99. doi: 10.1006/excr.2000.5131. Exp Cell Res. 2001. PMID: 11237525 Review.
-
The role of Wilms' tumor genes.J Med Invest. 1999 Aug;46(3-4):130-40. J Med Invest. 1999. PMID: 10687307 Review.
Cited by
-
Physical and functional interaction between WT1 and p53 proteins.Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5100-4. doi: 10.1073/pnas.90.11.5100. Proc Natl Acad Sci U S A. 1993. PMID: 8389468 Free PMC article.
-
Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma.Am J Pathol. 1995 Feb;146(2):344-56. Am J Pathol. 1995. PMID: 7856747 Free PMC article.
-
The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3.Mol Cell Biol. 1995 Mar;15(3):1522-35. doi: 10.1128/MCB.15.3.1522. Mol Cell Biol. 1995. PMID: 7862145 Free PMC article.
-
High affinity binding sites for the Wilms' tumour suppressor protein WT1.Nucleic Acids Res. 1995 Jan 25;23(2):277-84. doi: 10.1093/nar/23.2.277. Nucleic Acids Res. 1995. PMID: 7862533 Free PMC article.
-
Transcriptional repression by Msx-1 does not require homeodomain DNA-binding sites.Mol Cell Biol. 1995 Feb;15(2):861-71. doi: 10.1128/MCB.15.2.861. Mol Cell Biol. 1995. PMID: 7823952 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Molecular Biology Databases